Intellia Therapeutics (NTLA) Insider Trading & Ownership $13.38 +0.48 (+3.72%) (As of 12/16/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Intellia Therapeutics (NASDAQ:NTLA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$1.09 M Get NTLA Insider Trade Alerts Want to know when executives and insiders are buying or selling Intellia Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NTLA Insider Buying and Selling by Quarter Ad Behind the MarketsWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.Click here for the ticker >>> Intellia Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/2/2024Michael P DubeCAOSell2,012$19.01$38,248.12 7/1/2024Eliana ClarkEVPSell405$22.93$9,286.65 3/4/2024James BastaEVPSell2,297$32.99$75,778.03 1/8/2024Laura Sepp-LorenzinoEVPSell2,275$28.87$65,679.25 1/3/2024David LebwohlEVPSell5,843$29.46$172,134.78 1/3/2024Glenn GoddardCFOSell5,365$29.46$158,052.90 1/3/2024John M LeonardCEOSell19,223$29.46$566,309.58 (Data available from 1/1/2013 forward) NTLA Insider Trading Activity - Frequently Asked Questions Who is on Intellia Therapeutics's Insider Roster? The list of insiders at Intellia Therapeutics includes David Lebwohl, Eliana Clark, Glenn Goddard, James Basta, John M Leonard, Laura Sepp-Lorenzino, Michael P Dube, and Muna Bhanji. Learn more on insiders at NTLA. What percentage of Intellia Therapeutics stock is owned by insiders? 3.20% of Intellia Therapeutics stock is owned by insiders. Learn more on NTLA's insider holdings. Which Intellia Therapeutics insiders have been selling company stock? The following insiders have sold NTLA shares in the last 24 months: David Lebwohl ($172,134.78), Eliana Clark ($248,870.25), Glenn Goddard ($248,361.57), James Basta ($75,778.03), John M Leonard ($814,611.91), Laura Sepp-Lorenzino ($159,001.93), Michael P Dube ($38,248.12), and Muna Bhanji ($90,924.05). How much insider selling is happening at Intellia Therapeutics? Insiders have sold a total of 56,785 Intellia Therapeutics shares in the last 24 months for a total of $1,847,930.64 sold. Intellia Therapeutics Key ExecutivesDr. John M. Leonard M.D. (Age 67)President, CEO & Director Compensation: $1.06MMr. Glenn G. Goddard CPA (Age 53)Executive VP, CFO & Treasurer Compensation: $630.91kDr. Laura Sepp-Lorenzino Ph.D. (Age 63)Executive VP & Chief Scientific Officer Compensation: $670.58kMr. James E. Basta Esq. (Age 58)J.D., Executive VP, General Counsel & Corporate Secretary Compensation: $616.15kDr. David Lebwohl M.D. (Age 69)Executive VP & Chief Medical Officer Compensation: $671.42kMr. Derek Hicks (Age 50)Executive VP & Chief Business Officer Compensation: $823.42kMr. Nessan Bermingham Ph.D. (Age 51)Founder & Member of Scientific Advisor Board Compensation: $1.38MDr. Rachel E. Haurwitz Ph.D. (Age 38)Co-Founder Dr. Andrew May Ph.D.Founder and Member of Scientific Advisor BoardDr. Jennifer A. Doudna Ph.D. (Age 60)Founder & Member of Scientific Advisor Board More Insider Trading Tools from MarketBeat Related Companies Cytokinetics Insider Selling Viking Therapeutics Insider Selling BridgeBio Pharma Insider Selling Crinetics Pharmaceuticals Insider Selling TG Therapeutics Insider Selling Krystal Biotech Insider Selling ADMA Biologics Insider Selling Ultragenyx Pharmaceutical Insider Selling Arcellx Insider Selling Apellis Pharmaceuticals Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024? This page (NASDAQ:NTLA) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.